The establishment of connections between biochemical defects and clinical d
isease is a major goal of modern molecular genetics. In this review, we exa
mine the current literature that relates defects in the two major DNA doubl
e-strand-break repair pathways - homologous recombination and nonhomologous
end-joining - with the development of human tumors. Although definitive pr
oof has yet to be obtained, the current literature is highly suggestive of
such a link.